Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for Prevention of Oral Mucositis in Pediatric HSCT
NCT00728585Phase 2Withdrawn
- Sponsor
- Children's Oncology Group
- Start
- Mar 2008
- Primary completion
- May 2009
- Modality
- Cytokines & Interferons
01
Overview
Phase 2, randomised, double-blind trial in oral mucositis (OM) comparing Palifermin Arm with Placebo Arm (2 arms). Primary endpoint: Incidence of WHO grade 3 or 4 oral mucositis. Planned start Mar 2008; status: withdrawn.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00728585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728585.